A14-4    Number of reported cases of salmonellosis, by serotype, England and Wales, 2000-2010

A15-1    The epidemiology of antimicrobial resistance at the human—animal interface is invariably complex

A15-2    Flow of samples, isolates, and data in the Danish Integrated Antimicrobial Resistance and Antimicrobial Usage Monitoring Programme—DANMAP

A15-3    Comparison of the sales of veterinary antibacterial agents between 10 European countries (mg per kg meat produced)

A15-4    The total consumption of fluoroquinolones in Danish food-animal production, following voluntary and regulatory efforts to reduce the amounts used in 1999 and 2002, respectively

A15-5    Resistance (%) to erythromycin among Enterococcus faecium and Enterococcus faecalis from swine and the consumption of macrolides in swine, Denmark

A15-6    Resistance (%) to vancomycin in Enterococcus faecium from broilers and the consumption of avoparcin, Denmark

A15-7    Prevalence of ceftiofur resistance (moving average of the current quarter and the previous two quarters) among retail chicken Escherichia coli, and retail chicken and human clinical Salmonella enterica serovar Heidelberg isolates during 2003-2008 in Québec

A15-8    Sales of antimicrobials for therapeutic use in farmed fish in Norway versus produced biomass

A16-1    Illustration of the five stages through which pathogens of animals evolve to cause diseases confined to humans


WO-1    Wicked Problems

WO-2    The Seven Most Common Food-Borne Pathogens in the United States

WO-3    Recent Food-borne Outbreaks: The Changing Nature of the “Threat,”

WO-4    Molecular Methods for Pathogen Discovery

A16-1    Five Stages Leading to Endemic Human Diseases

A16-2    Transitions Between Stages

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement